Agilent Technologies Inc (A)

Add to Watchlists
Create an Alert
69.59 -2.15  -3.00% NYSE Aug 23, 14:11 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/19/2019 13:30 PST Misc Agilent Technologies Inc Fourth Quarter Earnings Conference Call in 2019
11/19/2019 Earnings Agilent Technologies Inc Fourth Quarter Earnings in 2019 Release
08/14/2019 13:30 PDT Misc Agilent Technologies Inc Third Quarter Earnings Conference Call in 2019
08/14/2019 Earnings Agilent Technologies Inc Third Quarter Earnings in 2019 Release
07/01/2019 Dividends Amount: 0.164, Declared Date: May 22 2019, Pay Date: Jul 24 2019
05/14/2019 13:30 EDT Misc Agilent Technologies Inc Second Quarter Earnings Conference Call in 2019
05/14/2019 Earnings Agilent Technologies Inc Second Quarter Earnings in 2019 Release
04/01/2019 Dividends Amount: 0.164, Declared Date: Mar 20 2019, Pay Date: Apr 24 2019
03/20/2019 08:00 PDT Misc Agilent Technologies Inc Annual General Meeting in 2018
02/20/2019 13:30 PST Misc Agilent Technologies Inc First Quarter Earnings Conference Call in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.agilent.com
  • Investor Relations URL: http://www.investor.agilent.com/phoenix.zhtml?c=103274&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Nov. 19, 2019
  • Last Earnings Release: Aug. 14, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jul. 01, 2019
  • Description: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (46% of fiscal 2018 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (19%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse with operations in the U.S. (29%) and China (21%) representing the largest country concentrations.

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 3.66%
FIW First Trust Water ETF 3.36%
LS.TO Middlefield Healthcare&Life Sciences ETF 2.11%
THISX T. Rowe Price Health Sciences I 1.98%
PMEGX T. Rowe Price Instl Mid-Cap Equity Gr 1.61%
MSJFX Invesco Oppenheimer Main Street R5 1.60%
FVUSA04AZ9 JNL/T. Rowe Price Mid-Cap Growth I 1.56%
RRMGX T. Rowe Price Mid-Cap Growth R 1.55%
SUSA iShares MSCI USA ESG Select ETF 1.55%
BME BlackRock Health Sciences 1.16%
MEFNX MassMutual Select Mid Cap Growth R3 1.14%
JKH iShares Morningstar Mid-Cap Growth ETF 1.09%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("A","name")
  • Description: =YCI("A","description")
  • Sector: =YCI("A","sector")
  • Industry: =YCI("A","industry")
  • Est. Current Fiscal Year End: =YCI("A","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.